BlackRock Inc. Sells 781,572 Shares of Keurig Dr Pepper Inc (NYSE:KDP)

Share on StockTwits

BlackRock Inc. reduced its position in shares of Keurig Dr Pepper Inc (NYSE:KDP) by 10.2% in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 6,869,611 shares of the company’s stock after selling 781,572 shares during the period. BlackRock Inc. owned about 0.49% of Keurig Dr Pepper worth $198,532,000 at the end of the most recent quarter.

A number of other hedge funds have also recently made changes to their positions in the stock. Prudential Financial Inc. lifted its holdings in Keurig Dr Pepper by 426.3% during the 2nd quarter. Prudential Financial Inc. now owns 3,429,881 shares of the company’s stock valued at $99,124,000 after purchasing an additional 2,778,138 shares during the last quarter. Bank of New York Mellon Corp lifted its holdings in Keurig Dr Pepper by 3.5% during the 2nd quarter. Bank of New York Mellon Corp now owns 1,146,864 shares of the company’s stock valued at $33,144,000 after purchasing an additional 39,069 shares during the last quarter. Jennison Associates LLC lifted its holdings in Keurig Dr Pepper by 10.8% during the 2nd quarter. Jennison Associates LLC now owns 957,104 shares of the company’s stock valued at $27,660,000 after purchasing an additional 93,636 shares during the last quarter. AustralianSuper Pty Ltd lifted its holdings in Keurig Dr Pepper by 83.3% during the 2nd quarter. AustralianSuper Pty Ltd now owns 950,870 shares of the company’s stock valued at $27,480,000 after purchasing an additional 432,032 shares during the last quarter. Finally, First Trust Advisors LP lifted its holdings in Keurig Dr Pepper by 27.5% during the 2nd quarter. First Trust Advisors LP now owns 909,151 shares of the company’s stock valued at $26,274,000 after purchasing an additional 196,239 shares during the last quarter. 19.58% of the stock is owned by hedge funds and other institutional investors.

In other Keurig Dr Pepper news, Director Robert S. Singer purchased 3,500 shares of the stock in a transaction dated Friday, November 8th. The stock was bought at an average price of $29.39 per share, for a total transaction of $102,865.00. Following the transaction, the director now directly owns 53,001 shares in the company, valued at $1,557,699.39. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, insider Mary Beth Denooyer purchased 6,000 shares of the stock in a transaction dated Tuesday, September 3rd. The shares were acquired at an average price of $26.85 per share, with a total value of $161,100.00. The disclosure for this purchase can be found here. In the last quarter, insiders have bought 78,000 shares of company stock valued at $2,132,265. 0.44% of the stock is owned by corporate insiders.

Shares of NYSE:KDP opened at $30.20 on Wednesday. Keurig Dr Pepper Inc has a one year low of $24.52 and a one year high of $32.00. The company has a 50 day moving average of $28.12 and a 200-day moving average of $28.32. The company has a debt-to-equity ratio of 0.57, a current ratio of 0.35 and a quick ratio of 0.23. The stock has a market cap of $42.72 billion, a price-to-earnings ratio of 29.04, a P/E/G ratio of 1.61 and a beta of 0.45.

Keurig Dr Pepper (NYSE:KDP) last issued its quarterly earnings results on Thursday, November 7th. The company reported $0.32 EPS for the quarter, topping the consensus estimate of $0.31 by $0.01. Keurig Dr Pepper had a net margin of 10.13% and a return on equity of 7.27%. The company had revenue of $2.87 billion during the quarter, compared to analysts’ expectations of $2.86 billion. During the same quarter in the previous year, the company earned $0.30 EPS. Keurig Dr Pepper’s revenue was up 5.1% on a year-over-year basis. Equities research analysts anticipate that Keurig Dr Pepper Inc will post 1.22 earnings per share for the current year.

The firm also recently declared a quarterly dividend, which will be paid on Friday, January 17th. Stockholders of record on Friday, January 3rd will be given a dividend of $0.15 per share. This represents a $0.60 annualized dividend and a dividend yield of 1.99%. The ex-dividend date of this dividend is Thursday, January 2nd. Keurig Dr Pepper’s dividend payout ratio is 57.69%.

KDP has been the subject of several analyst reports. Royal Bank of Canada set a $31.00 price target on shares of Keurig Dr Pepper and gave the company a “buy” rating in a report on Friday, August 9th. Guggenheim reaffirmed a “hold” rating on shares of Keurig Dr Pepper in a research note on Friday, September 27th. SunTrust Banks set a $35.00 target price on shares of Keurig Dr Pepper and gave the stock a “buy” rating in a research note on Friday, September 27th. Bank of America boosted their target price on shares of Keurig Dr Pepper from $30.00 to $33.00 and gave the stock a “buy” rating in a research note on Friday, August 9th. Finally, Morgan Stanley boosted their target price on shares of Keurig Dr Pepper from $24.00 to $26.00 and gave the stock an “underweight” rating in a research note on Friday, November 8th. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating and nine have issued a buy rating to the company’s stock. The company presently has a consensus rating of “Buy” and an average price target of $30.67.

About Keurig Dr Pepper

Keurig Dr Pepper Inc operates as a beverage company in the United States and internationally. It operates through four segments: Beverage Concentrates, Packaged Beverages, Latin America Beverages, and Coffee Systems. The Beverage Concentrates segment manufactures and sells beverage concentrates. This segment also manufactures beverage concentrates into syrup.

Featured Article: Real Estate Investment Trust (REIT) ETF

Institutional Ownership by Quarter for Keurig Dr Pepper (NYSE:KDP)

Receive News & Ratings for Keurig Dr Pepper Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Keurig Dr Pepper and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


 
© 2006-2019 BBNS.